✦ LIBER ✦

RECOMBINANT α2-INTERFERON TREATMENT IN CHILDREN WITH CHRONIC HEPATITIS B

✍ Scribed by La Banda, Faustino; Moreno, MercedesRuiz; Carreño, Vincente; Bartolome, Javier; Gutiez, Julia; Y Cajal, SantiagoRamon; Moreno, Alberto; Mora, Ignacio; Porres, JuanCarlos

Book ID: 122387402
Publisher: The Lancet
Year: 1988
Tongue: English
Weight: 174 KB
Volume: 331
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(88)91109-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

RECOMBINANT α2-INTERFERON TREATMENT IN C

RECOMBINANT α2-INTERFERON TREATMENT IN CHILDREN WITH CHRONIC HEPATITIS B

✍ Lai, C.L.; Lin, H.J.; Wu, P.C. 📂 Article 📅 1988 🏛 The Lancet 🌐 English ⚖ 148 KB

Treatment of chronic delta hepatitis wit

Treatment of chronic delta hepatitis with α-2 recombinant interferon

✍ Rizzetto, M.; Rosina, F.; Saracco, G.; Bellando, P.C.; Actis, G.C.; Bonino, F.; 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 277 KB

Treatment of chronic hepatitis C with re

Treatment of chronic hepatitis C with recombinant alfa interferon 2B

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Treatment of chronic hepatitis B with α-

Treatment of chronic hepatitis B with α-interferon

✍ Carren̄o, Vincente; Quiroga, Juan Antonio 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Treatment of children with chronic hepat

Treatment of children with chronic hepatitis C with recombinant interferon-α: A pilot study

✍ Mercedes Ruiz-Moreno; Maria José Rua; Inmaculada Castillo; Maria Dolores García- 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 1 views

Twelve children with chronic non-A, non-B hepatitis were entered in a pilot trial of recombinant interferon-alpha. Although all the children had hepatitis C virus RNA in serum, only five had antibodies against this virus. Children received 3 MU/m2 body surface area interferon-alpha 3 times/wk for 6

Recombinant leukocyte interferon treatme

Recombinant leukocyte interferon treatment of chronic hepatitis B

✍ Geoffrey Dusheiko; Adrian Dibisceglie; Sheila Bowyer; Evelyn Sachs; Marian Ritch 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 513 KB

We have investigated the efficacy of a relatively prolonged course of recombinant leukocyte interferon treatment in 14 chronic HBsAg-, HBeAg-, hepatitis B virus DNA-and DNA polymerasepositive carriers. a-Interferon was administered for 9 weeks. Six of 14 treated carriers have a sustained loss of HBe